Her days may not be consistent
but her medication should be
For your ADHD patients with afternoon symptom rebound,
discover proven 13-hour efficacy2
Continuous amphetamine release through the day1,3
Consistent symptom control from patient to patient2,4
Smooth PK profile1,5
Proven 13-hour efficacy2
Flexible dosing options5
Guaranteed Availability!
You Prescribe, We Deliver
ePrescribe to Perigon Pharmacy 360 for guaranteed availability, patient support, free, fast delivery, and the lowest available price for your patients.
DYANAVEL XR Resources
ADHD, Attention Deficit Hyperactivity Disorder; PK, pharmacokinetic.
References: 1. Pardo A, Kando JC, King TR, Rafla E, Herman BK. Single-dose pharmacokinetics of amphetamine extended-release tablets compared with amphetamine extended-release oral suspension. CNS Spectr. 2020;25(6):774-781. 2. Childress AC, Wigal SB, Brams MN, et al. Efficacy and safety of amphetamine extended-release oral suspension in children with attention-deficit/hyperactivity disorder. J Child Adolesc Psycholpharmacol. 2018;28(5):306-313. 3. Kando JC, King TR, Pardo A. A novel, modified release drug delivery technology containing amphetamine and methylphenidate ion-exchange complexes. Poster presented at: American Psychiatric Association Annual Meeting; May 1-3, 2021. 4. Cutler AJ, Childress AC, Pardo A, et al. Randomized, double-blind, placebo-controlled, fixed-dose study to evaluate the efficacy and safety of amphetamine extended-release tablets in adults with attention-deficit/hyperactivity disorder. J Clin Psychiatry. 2022;83(5):22m14438. 5. Dyanavel XR [package insert]. Tris Pharma, Inc., Monmouth Junction, NJ.